Nimodipine and Its Use in Cerebrovascular Disease: Evidence from Recent Preclinical and Controlled Clinical Studies

Author： Tomassoni Daniele   Lanari Alessia   Silvestrelli Giorgio   Traini Enea   Amenta Francesco  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.30, Iss.8, 2008-11, pp. : 744-766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Metabolic Syndrome and Cerebrovascular Disease: Suspicion and Evidence

By  

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-11 ,pp. : 64-75

Karger

Access to resources Recommend Favorite

Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease

By  

Cerebrovascular Diseases Extra, Vol. 6, Iss. 3, 2016-09 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Antihypertensive Drugs and Coronary Artery Disease: Evidence from Controlled Trials

By Verdecchia Paolo   Angeli Fabio  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 3, 2005-01 ,pp. : 119-124

Adis International

Access to resources Recommend Favorite

Vitamin B Status and Cognitive Performance in Preclinical and Clinical Alzheimer’s Disease: Data from the Kungsholmen Project

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 1, 2007-11 ,pp. : 23-31

Karger

Access to resources Recommend Favorite

Radioisotope stents for the prevention of restenosis: what did we learn from pre-clinical studies?

By Hehrlein Christoph  

International Journal of Cardiovascular Interventions, Vol. 1, Iss. 2, 1998-01 ,pp. : 77-80

Informa Healthcare

Access to resources Recommend Favorite